Astellas Americas' President James Robinson named to the 2016 PharmaVOICE 100
Aug 2, 2016
Astellas Americas’ President James (Jim) Robinson was recently named a 2016 PharmaVOICE 100 honoree in the July/August edition of PharmaVOICE magazine in recognition of his contributions to the life-sciences industry.
“Great ideas come from many places — internally and externally,” notes Jim in his PharmaVOICE profile. “I believe that collaboration with stakeholders across the spectrum — patients, providers, payers, regulators, policy makers, biopharmaceutical companies, and academicians — empower higher-quality work.”
The PharmaVOICE 100 honorees represent a broad cross section of the global life-sciences industry, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advertising, digital, marketing, technology, academia, and many other sectors. This diverse group of individuals also represents a wide variety of functional areas ranging from the clinic to the C-suite.
Honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; have affected positive changes in their own organizations through innovative and game-changing strategies and thinking; as well as giving back to their communities and other philanthropic causes.
To read Jim Robinson’s full profile, click here.